glp-1 obesity drug news today oct 2025 Employers weigh rising cost pressures Outlook for Obesity in 2026:

Most side effects are mild, like nausea, tiredness, or diarrhoea, and improve as your body adjusts

No EOF Notification 120775/26-11-2018 The EOF notification number does not constitute a marketing authorization license from EOF

Besides, the cost deters it from making its way into low- and middle-income countries, where people are not only most affected by obesity, but are also at risk of cardiovascular death, where it makes up nearly 80% of the global burden, according to the National Institutes of Health

Some Ozempic patients have filed legal complaints against Novo Nordisk, claiming that the semaglutide caused them to develop a separate vision disorder called NAION (which can cause sudden blindness)

Reversible optical transcription of supramolecular chirality into molecular chirality

Selank typically reduces evening anxiety within 12 weeks